Your browser doesn't support javascript.
loading
Effect of Alirocumab on Mortality After Acute Coronary Syndromes.
Steg, Philippe Gabriel; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Brégeault, Marie-France; Dalby, Anthony J; Diaz, Rafael; Edelberg, Jay M; Goodman, Shaun G; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Lecorps, Guillaume; Mahaffey, Kenneth W; Moryusef, Angèle; Ostadal, Petr; Parkhomenko, Alexander; Pordy, Robert; Roe, Matthew T; Tricoci, Pierluigi; Vogel, Robert; White, Harvey D; Zeiher, Andreas M; Schwartz, Gregory G.
Afiliación
  • Steg PG; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université de Paris, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France (P.G.S.).
  • Szarek M; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.).
  • Bhatt DL; State University of New York, Downstate School of Public Health, Brooklyn (M.S.).
  • Bittner VA; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA (D.L.B.).
  • Brégeault MF; Division of Cardiovascular Disease, University of Alabama at Birmingham. (V.A.B.).
  • Dalby AJ; Sanofi, Paris, France (M.F.B., C.H., G.L.).
  • Diaz R; Milpark Hospital, Johannesburg, Republic of South Africa (A.J.D.).
  • Edelberg JM; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Argentina (R.D.).
  • Goodman SG; Sanofi, Bridgewater, NJ (J.M.E., A.M.).
  • Hanotin C; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada and St. Michael's Hospital, University of Toronto, Canada (S.G.G.).
  • Harrington RA; Sanofi, Paris, France (M.F.B., C.H., G.L.).
  • Jukema JW; Stanford Center for Clinical Research, Department of Medicine, Stanford University, CA (R.A.H., K.W.M.).
  • Lecorps G; Department of Cardiology, Leiden University Medical Center, the Netherlands (J.W.J.).
  • Mahaffey KW; Sanofi, Paris, France (M.F.B., C.H., G.L.).
  • Moryusef A; Stanford Center for Clinical Research, Department of Medicine, Stanford University, CA (R.A.H., K.W.M.).
  • Ostadal P; Sanofi, Bridgewater, NJ (J.M.E., A.M.).
  • Parkhomenko A; Na Homolce Hospital, Prague, Czech Republic (P.O.).
  • Pordy R; Institute of Cardiology, Kyiv, Ukraine (A.P.).
  • Roe MT; Regeneron Pharmaceuticals Inc, Tarrytown, NY (R.P.).
  • Tricoci P; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.T.R., P.T.).
  • Vogel R; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC (M.T.R.).
  • White HD; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.T.R., P.T.).
  • Zeiher AM; University of Colorado Denver (R.V.).
  • Schwartz GG; Green Lane Cardiovascular Services Auckland City Hospital, New Zealand (H.D.W.).
Circulation ; 140(2): 103-112, 2019 07 09.
Article en En | MEDLINE | ID: mdl-31117810
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Anticuerpos Monoclonales Humanizados / Hipercolesterolemia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Anticuerpos Monoclonales Humanizados / Hipercolesterolemia Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Año: 2019 Tipo del documento: Article